Sonic Healthcare Limited
ASX: SHL.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James Pacey Newcombe
- Employees
- 42,000
- Headquarters
- Sydney, Australia
- IPO year
- 1999
- Market cap
- A$9.4B
- Website
- https://www.sonichealthcare.com
Loading SHL…
Loading profile data…Frequently asked questions about SHL
What does Sonic Healthcare Limited (SHL.AX) do?
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular patholo...
Where does SHL.AX trade?
Sonic Healthcare Limited (SHL.AX) trades on the Australian Securities Exchange.
What sector is SHL.AX in?
Sonic Healthcare Limited (SHL.AX) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Sonic Healthcare Limited?
James Pacey Newcombe is the chief executive officer of Sonic Healthcare Limited (SHL.AX).
Where is Sonic Healthcare Limited headquartered?
Sonic Healthcare Limited is headquartered in Australia.
Does SHL.AX pay a dividend?
Yes — Sonic Healthcare Limited (SHL.AX) paid a trailing twelve-month dividend of AUD 1.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SHL.AX go public?
Sonic Healthcare Limited (SHL.AX) completed its initial public offering in 1999.